On September 4, 2012, Durata Therapeutics, Inc. (the "Company") announced its financial results for the quarter ended June 30, 2012. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is furnished to comply with Item 2.02 of Form 8-K, and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

(d) Exhibits.

99.1    Press Release of Durata Therapeutics, Inc., dated September 4, 2012,
        entitled "Durata Therapeutics, Inc. Reports Second Quarter 2012 Financial
        and Corporate Results".